☆ 4.6 Article

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

FRONTIERS IN MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, Research & Experimental

Metabolic comorbidities of psoriasis (Review)

Daciana Elena Branisteanu et al.

Summary: Psoriasis is a chronic inflammatory and immune-mediated condition that may affect the entire body, not just the skin. Patients with psoriasis are more likely to have comorbidities such as obesity and diabetes, and early recognition of these comorbidities is crucial for timely treatment. Dermatologists, who are often the first medical contact for psoriasis patients, play an important role in informing patients about the association between psoriasis and comorbidities, and devising prevention and treatment plans.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)

添加到收藏夹

Article Dermatology

Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: A prospective analysis in Corrona Psoriasis Registry

Clinton W. Enos et al.

Summary: The study found that obesity and a history of diabetes reduce the likelihood of patients responding to biologic treatment, especially in achieving certain levels of disease improvement. Obesity is associated with lower response to TNFi and IL-17i biologics, while diabetes is associated with poorer outcomes when using IL-17i therapy, independent of obesity.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

添加到收藏夹

Review Dermatology

Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review

Joseph F. Merola et al.

Summary: Metabolic syndrome (MetS) is a common comorbidity of psoriasis that affects the efficacy and safety of psoriasis treatment. There is limited evidence on the efficacy of biologics in MetS patients, and the impact of obesity on treatment response further complicates interpretation of the effect of MetS. Special attention should be given to cardiovascular safety and exacerbation of related conditions in patients with concomitant MetS.

DERMATOLOGY AND THERAPY (2022)

添加到收藏夹

Article Medicine, General & Internal

Psoriasis

Christopher E M Griffiths et al.

LANCET (2021)

添加到收藏夹

Review Dermatology

Diabetes Detection and Prevention in Dermatology

Alexandra Ngo et al.

Summary: Dermatologists play a crucial role in detecting and preventing diabetes, by improving early detection of both diabetes and prediabetes, and assisting patients with diabetes or at risk of developing diabetes.

DERMATOLOGY PRACTICAL & CONCEPTUAL (2021)

添加到收藏夹

Article Dermatology

Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis

Andreas Pinter et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2020)

添加到收藏夹

Article Medicine, General & Internal

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study

Rosa Parisi et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Exposure-Response Modeling to Characterize the Relationship Between Ixekizumab Serum Drug Concentrations and Efficacy Responses at Week 12 in Patients With Moderate to Severe Plaque Psoriasis

Emmanuel Chigutsa et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2018)

添加到收藏夹

Article Dermatology

The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised, controlled Phase 3 studies of patients with moderate-to-severe plaque psoriasis

K. Reich et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

K. B. Gordon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Incidence and predictors of early adulthood pre-diabetes/type 2 diabetes, among Iranian adolescents: the Tehran Lipid and Glucose Study

Mohammadhassan Mirbolouk et al.

PEDIATRIC DIABETES (2016)

添加到收藏夹

Article Medicine, General & Internal

Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis

M. Gyldenlove et al.

JOURNAL OF INTERNAL MEDICINE (2015)

添加到收藏夹

Article Medicine, General & Internal

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Christopher E. M. Griffiths et al.

LANCET (2015)

添加到收藏夹

Review Medicine, General & Internal

Management of moderate to severe psoriasis in patients with metabolic comorbidities

Paolo Gisondi et al.

FRONTIERS IN MEDICINE (2015)

添加到收藏夹

Review Dermatology

Psoriasis and the Risk of Diabetes Mellitus A Systematic Review and Meta-analysis

April W. Armstrong et al.

JAMA DERMATOLOGY (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.